Literature DB >> 16078047

Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR).

Esther van de Vosse1, Soegianto Ali, Adriëtte W de Visser, Charles Surjadi, Suwandhi Widjaja, Albert M Vollaard, Jaap T van Dissel.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is the affected protein in cystic fibrosis (CF). The high rate of CF carriers has led to speculation that there must be, similar to the sickle cell haemoglobin advantage in malaria, a selective advantage for heterozygotes. Such a selective advantage may be conferred through reduced attachment of Salmonella typhi to intestinal mucosa, thus providing resistance to typhoid fever. We tested this hypothesis by genotyping patients and controls in a typhoid endemic area in Indonesia for two highly polymorphic markers in CFTR and the most common CF mutation. We found an association between genotypes in CFTR and susceptibility to typhoid fever (OR=2.6). These analyses suggest that the role CFTR plays in vitro in S. typhi infection is also important for infection in the human population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078047     DOI: 10.1007/s00439-005-0005-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.

Authors:  Ruth Kornreich; Josef Ekstein; Lisa Edelmann; Robert J Desnick
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822

2.  Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers.

Authors:  N Morral; T Dörk; R Llevadot; V Dziadek; B Mercier; C Férec; B Costes; E Girodon; J Zielenski; L C Tsui; B Tümmler; X Estivill
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

3.  The estimated incidence of cystic fibrosis in Japan.

Authors:  Y Yamashiro; T Shimizu; S Oguchi; T Shioya; S Nagata; Y Ohtsuka
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-05       Impact factor: 2.839

4.  A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers.

Authors:  L B Jorde; G M Lathrop
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

5.  Salmonella typhi uses CFTR to enter intestinal epithelial cells.

Authors:  G B Pier; M Grout; T Zaidi; G Meluleni; S S Mueschenborn; G Banting; R Ratcliff; M J Evans; W H Colledge
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

6.  Cystic fibrosis patients from the Black Sea region: the 1677delTA mutation.

Authors:  D Angelicheva; K Boteva; A Jordanova; A Savov; A Kufardjieva; A Tolun; M Telatar; A Akarsubaşi; F Köprübaşi; S Aydoğdu
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

7.  The type IVB pili of Salmonella enterica serovar Typhi bind to the cystic fibrosis transmembrane conductance regulator.

Authors:  Inez S M Tsui; Cecilia M C Yip; Jim Hackett; Christina Morris
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis.

Authors:  S K Kabra; Madhulika Kabra; Rakesh Lodha; S Shastri; M Ghosh; R M Pandey; Arti Kapil; Gunjan Aggarwal; Vishal Kapoor
Journal:  Indian Pediatr       Date:  2003-07       Impact factor: 1.411

9.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

10.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

View more
  13 in total

1.  CFTR mutations and reproductive outcomes in a population isolate.

Authors:  Irene Gallego Romero; Carole Ober
Journal:  Hum Genet       Date:  2007-09-28       Impact factor: 4.132

Review 2.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 3.  Genetics of susceptibility to infection with enteric pathogens.

Authors:  Jose Flores; Pablo C Okhuysen
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

4.  PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever.

Authors:  S Ali; A M Vollaard; S Widjaja; C Surjadi; E van de Vosse; J T van Dissel
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Evaluating candidate agents of selective pressure for cystic fibrosis.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

Review 6.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 7.  [Genetic susceptibility to infections].

Authors:  S J Ott; S Schreiber
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

Review 8.  Clinical Phenotypes of Cystic Fibrosis Carriers.

Authors:  Philip M Polgreen; Alejandro P Comellas
Journal:  Annu Rev Med       Date:  2022-01-27       Impact factor: 13.739

9.  Mutations in the MESP2 gene cause spondylothoracic dysostosis/Jarcho-Levin syndrome.

Authors:  Alberto S Cornier; Karen Staehling-Hampton; Kym M Delventhal; Yumiko Saga; Jean-Francois Caubet; Nobuo Sasaki; Sian Ellard; Elizabeth Young; Norman Ramirez; Simon E Carlo; Jose Torres; John B Emans; Peter D Turnpenny; Olivier Pourquié
Journal:  Am J Hum Genet       Date:  2008-05-15       Impact factor: 11.025

10.  Common CFTR gene variants influence body composition and survival in rural Ghana.

Authors:  Maris Kuningas; David van Bodegom; Linda May; Johannes J Meij; P Eline Slagboom; Rudi G J Westendorp
Journal:  Hum Genet       Date:  2009-11-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.